黑料吃瓜群网

Remain on aspirin to avoid repeat heart attack, stroke


Monday, 02 October, 2017

Remain on aspirin to avoid repeat heart attack, stroke

Heart attack and stroke victims who stop long-term, low-dose aspirin therapy are at increased risk of suffering a cardiovascular event.

Aspirin, taken in low doses, is used to help reduce the risk for recurrent heart attack or stroke. Aspirin inhibits clotting, lowering the risk of cardiovascular events. Nearly 10% to 20% of heart attack survivors stop daily aspirin use within the first three years following their event. In broader patient settings, discontinuation rates of up to 30% and poor aspirin compliance in up to 50% of patients have been reported,聽according to new research published in the American Heart Association鈥檚 journal聽.

To study the health effects of stopping aspirin therapy, Swedish researchers examined the records of 601,527 people who took low-dose aspirin for heart attack and stroke prevention between 2005 and 2009. Participants were older than 40, cancer-free and had an adherence rate of greater than 80%聽in the first year of treatment.

In three years of follow-up, there were 62,690 cardiovascular events. Researchers also found:

  • one out of every 74 patients who stopped taking aspirin had an additional cardiovascular event per year;
  • a 37% higher rate of cardiovascular events for those who stopped aspirin therapy compared to those who continued; and
  • an elevated risk of cardiovascular events that increased shortly after discontinuation of therapy and did not appear to diminish over time.

鈥淟ow-dose aspirin therapy is a simple and inexpensive treatment,鈥 said Dr Johan Sundstrom, PhD, lead author and professor of epidemiology at in Sweden. 鈥淎s long as there鈥檚 no bleeding or any major surgery scheduled, our research shows the significant public health benefits that can be gained when patients stay on aspirin therapy.鈥

Studies have suggested patients experience a 鈥榬ebound effect鈥 after stopping aspirin treatment, possibly due to increased clotting levels from the loss of aspirin鈥檚 blood-thinning effects. Because of the large number of patients on aspirin and the high number who stop treatment, the importance of a rebound effect may be significant, Sundstrom said.

鈥淲e hope our research may help physicians, healthcare providers and patients make informed decisions on whether or not to stop aspirin use,鈥 Dr Sundstrom said.

Image credit: 漏stock.adobe.com/au/Martina

Originally published

Related News

Victoria's Q3 median ED wait times the lowest on record

Victoria's quarter three performance data (January–March) has shown improvement across...

Irregularities in a clinician's cases prompt 15-month lookback

St Vincent's 黑料吃瓜群网 Sydney has detailed a 15-month lookback review — prompted by...

Two researchers receive $899,000 in cardiovascular funding

In heart-related news this Heart Week (5–11 May), two University of Newcastle researchers...



Content from other channels on our network


  • All content Copyright 漏 2025 黑料吃瓜群网-Farrow Pty Ltd